Walvax Biotechnology Co., Ltd. (300142.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Walvax Biotechnology Co., Ltd.
—
Walvax Biotechnology Co., Ltd. is led by CEO Wei Yao, employs 1,981 people, headquartered in Kunming, CN, publicly traded since 2010.
Walvax Biotechnology Co., Ltd. (300142.SZ) stock trades at $12.46 with a market capitalization of $21.51B. The stock is valued at a price-to-earnings (P/E) ratio of 112.08, price-to-book of 3.08, price-to-sales of 10.25. Over the past 52 weeks the stock has ranged between $10.88 and $16.97, and currently trades 26.6% below its 52-week high. It pays a dividend yielding 1.15%.
On profitability, Walvax Biotechnology Co., Ltd. generates a return on equity (ROE) of 1.97%, an operating margin of -7.33%, a net profit margin of 9.00%.
The balance sheet shows a debt-to-equity ratio of 0.18 (debt below half of shareholders' equity), a current ratio of 2.07.
300142.SZ has an average daily trading volume of 97,771,406 shares, a beta of 0.38 (historically less volatile than the overall market), 1.60B shares outstanding.
Official website: www.walvax.com
Walvax Biotechnology Co., Ltd. (300142.SZ) — frequently asked questions
What is Walvax Biotechnology Co., Ltd. (300142.SZ) stock price today?
Walvax Biotechnology Co., Ltd. (300142.SZ) is currently trading at $12.46, down 6.1% today.
What is 300142.SZ P/E ratio?
Walvax Biotechnology Co., Ltd.'s P/E ratio is 112.08. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 300142.SZ return on equity (ROE)?
Walvax Biotechnology Co., Ltd.'s return on equity (ROE) is 1.97%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Walvax Biotechnology Co., Ltd.'s market cap?
Walvax Biotechnology Co., Ltd. has a market capitalization of $21.51B.
Does 300142.SZ pay a dividend?
Yes. Walvax Biotechnology Co., Ltd. currently yields 1.15%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 300142.SZ carry?
Walvax Biotechnology Co., Ltd. has a debt-to-equity ratio of 0.18. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 300142.SZ's profit margin?
Walvax Biotechnology Co., Ltd. reports a net profit margin of 9.00% — the share of revenue left after every cost, including tax and interest.
What sector is 300142.SZ in?
Walvax Biotechnology Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 300142.SZ listed on?
Walvax Biotechnology Co., Ltd. trades on SHZ under the ticker 300142.SZ.
What is 300142.SZ's 52-week range?
Over the last year Walvax Biotechnology Co., Ltd. has traded between $10.88 and $16.97.
Related — Stocks
Popular Stocks
Screens 300142.SZ currently matches
On the figures above, Walvax Biotechnology Co., Ltd. passes the filters for 12 of our ready-made screens, among them Dividend Stocks, Low Debt Stocks, Day Losers Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.